Source link : https://www.newshealth.biz/health-news/novel-cell-based-therapy-promising-for-alzheimers-disease/
PHILADELPHIA — An experimental, cell-based therapy met its primary safety and secondary efficacy endpoints in a phase 2b study on mild Alzheimer’s disease (AD). The results “exceeded our expectations” in terms of “consistent positive efficacy signals” across different domains, including cognition, quality of life, and neuroimaging results, Joshua Hare, MD, co-founder, chief science officer, and […]
Author : News Health
Publish date : 2024-07-30 19:26:54
Copyright for syndicated content belongs to the linked Source.
inHealth